Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group

GG Dark, AH Calvert, R Grimshaw, C Poole, K Swenerton, S Kaye, R Coleman, G Jayson, T Le, S Ellard, M Trudeau1, P Vasey, M Hamilton, T Cameron, E Barrett, W Walsh, L McIntosh, E Eisenhauer

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)1859-1866
    JournalJ Clin Oncol
    Publication statusPublished - 2005

    Cite this